PLCG2 and Alzheimer disease: In line with these findings, we now demonstrate that PLCγ2-P522R variant decreases the β-amyloid plaque count and coverage in the brain tissue of female APP/PS1 mice, which is a less aggressive mouse model of AD as compared to 5XFAD mouse model.